1472660-29-9

Upstream product

• 1472660-16-4 (2R,4S)-8-(benzyloxy)-4-hydroxy-2-methyloct-6-yn-1-yl 2,2-dimethylpropanoate 
• 1472660-14-2 (2R)-2-methyl-3-[(2S)-oxiran-2-yl]propyl 2,2-dimethylpropanoate 
• 1472660-12-0 (2R,4S)-4,5-dihydroxy-2-methylpentyl 2,2-dimethylpropanoate 
• 1472660-10-8 (2R)-3-[(2S)-1,4-dioxaspiro[4.5]dec-2-yl]-2-methylpropan-1-ol 
• 1472660-08-4 (4R)-4-benzyl-3-{(2R)-3-[ (2S)-1,4-dioxaspiro[4.5]dec-2-yl]-2-methylpropanoyl}-1,3-oxazolidin-2-one 
• 1472660-27-7 (3R,5R)-9-(benzyloxy)-3-methylnon-1-en-7-yn-5-yl N-[(tert-butoxy)carbonyl]-N-methyl-D-phenylalaninate 
• 37553-65-4 N-tert-butoxycarbonyl-N-methyl-D-phenylalanine 
• 18942-49-9 Boc-D-Phe-OH 
• 673-06-3 D-(R)-phenylalanine 
• 1472660-06-2 (4R)-4-benzyl-3-{3-[(2S)-1,4-dioxaspiro[4.5]dec-2-yl]propanoyl}-1,3-oxazolidin-2-one 
• 1472660-04-0 3-[(2S)-1,4-dioxaspiro[4.5]dec-2-yl]propanoic acid 
• 726193-03-9 (S)-ethyl 3-(1,4-dioxaspiro[4.5]decan-2-yl)propanoate 
• 1472660-37-9 C₁₇H₃₀O₄ 
• 1472659-99-6 (3R,5S)-9-(benzyloxy)-3-methylnon-1-en-7-yn-5-ol 

Downstream Products

• 1472660-31-3 (3R,5R)-9-(benzyloxy)-3-methylnon-1-en-7-yn-5-yl N-[(2S,4R)-2,4-dimethylhex-5-enoyl]-N-methyl-D-phenylalaninate 
• 1472660-35-7 (3R,6S,8R,11R,13R)-3-benzyl-13-[4-(benzyloxy)but-2-yn-1-yl]-4,6,8,11-tetramethyl-1-oxa-4-azacyclotridec-9-ene-2,5-dione 

Relevant academic research and scientific papers

Synthetic studies toward (+)-spongidepsin

A convergent enantiomerically controlled synthetic effort toward (+)-spongidepsin is reported. The synthesis benefits from the use of readily available and inexpensive starting materials like D-mannitol and (-)-β-citronellene. Key transformations include Evans asymmetric methylation, Mitsunobu esterification, (1H-benzotriazol-1-yloxy) tripyrrolidinophosphonium hexafluorophosphate (PyBOP)-mediated amide formation for the preparation of a fully functionalized acyclic precursor, and ring-closing metathesis (RCM). Copyright